Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double‐Blind, Placebo‐Controlled Trial

Bone loss and fractures are common complications after cardiac transplantation (CTP). The aim of this study was to investigate whether intravenous ibandronate is an effective preventive option. Thirty‐five male cardiac transplant recipients received either ibandronate (IBN) 2 mg intravenously every...

Ausführliche Beschreibung